Parmax Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 4.73 | 6.30 | 9.39 |
| Operating Expense | 6.46 | 6.18 | 9.08 |
| Net Profit | -1.49 | -0.39 | -0.22 |
| Net Profit Margin | -31.50 | -6.19 | -2.34 |
| Earning Per Share | -4 | -1.05 | -0.58 |
| EBIDTA | -1.43 | 0.13 | 0.31 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 4.73 |
| Operating Expense | 6.46 |
| Net Profit | -1.49 |
| Net Profit Margin | -31.50 |
| Earning Per Share | -4.00 |
| EBIDTA | -1.43 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 11.05 | 15.42 | 18.25 |
| Operating Expenses Annual | 14.42 | 13.17 | 15.69 |
| Operating Profit Annual | -3.32 | 2.29 | 2.62 |
| Interest Annual | 0.62 | 0.37 | 0.39 |
| Depreciation | 1.71 | 1.88 | 1.93 |
| Net Profit Annual | -5.78 | -0.10 | 0.14 |
| Tax Annual | 0.12 | 0.15 | 0.16 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 11.05 |
| Operating Expenses Annual | 14.42 |
| Operating Profit Annual | -3.32 |
| Interest Annual | 0.62 |
| Depreciation | 1.71 |
| Net Profit Annual | -5.78 |
| Tax Annual | 0.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.41 | 1.05 | 2.75 |
| Cash Flow from Operations | -0.19 | 0.33 | 0.75 |
| Cash Flow from Investing | -1.59 | -0.94 | -1.53 |
| Cash Flow from Financing | 1.43 | -0.04 | -0.91 |
| Cash Flow at the End | 0.06 | 0.41 | 1.05 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.41 |
| Cash Flow from Operations | -0.19 |
| Cash Flow from Investing | -1.59 |
| Cash Flow from Financing | 1.43 |
| Cash Flow at the End | 0.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -30.05 | 14.85 | 14.41 |
| PBIT Margin (%) | -45.52 | 2.66 | 3.84 |
| PBT Margin (%) | 28.05 | -4.73 | -5.86 |
| Net PROFIT Margin (%) | -52.31 | -0.65 | 0.77 |
| Return On Networth / Equity (%) | TBA | -1.69 | 2.38 |
| Return On Networth /Employed (%) | TBA | 3.76 | 6.04 |
| Return On Assets (%) | -66.95 | -0.89 | 1.23 |
| Total Debt / Equity (X) | 1.91 | 0.89 | 0.94 |
| Asset Turnover Ratio (%) | 1.28 | 1.38 | 1.60 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -30.05 |
| PBIT Margin (%) | -45.52 |
| PBT Margin (%) | 28.05 |
| Net PROFIT Margin (%) | -52.31 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -66.95 |
| Total Debt / Equity (X) | 1.91 |
| Asset Turnover Ratio (%) | 1.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 9.27 | 9.50 | 10.44 |
| Total Current Assets Annual | 5.77 | 7.53 | 6.56 |
| Non Current Assets Annual | 9.56 | 10.08 | 11.42 |
| Total Shareholders Funds Annual | 0.07 | 5.86 | 5.96 |
| Total Assets Annual | 15.33 | 17.61 | 17.97 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 9.27 |
| Total Current Assets Annual | 5.77 |
| Non Current Assets Annual | 9.56 |
| Total Shareholders Funds Annual | 0.07 |
| Total Assets Annual | 15.33 |
No Data Availabe
